Clinical Trial Update: Pivotal Trial of SAT-014 for Trauma and Stressor-Related Disorder Symptoms [NA]

View source ↗

Summary

The document notes that the pivotal trial of SAT-014 for trauma- and stressor-related disorder symptoms has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adjustment Disorder
• Post-traumatic Stress Disorder

Drugs mentioned

• SAT-014

Snippet

Sponsor: S-Alpha Therapeutics, Inc. | Conditions: Post-traumatic Stress Disorder, Adjustment Disorders | NA | Status: COMPLETED